C57BL/6JCya-Timp1em1flox/Cya
Common Name:
Timp1-flox
Product ID:
S-CKO-06301
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Timp1-flox
Strain ID
CKOCMP-21857-Timp1-B6J-VA
Gene Name
Product ID
S-CKO-06301
Gene Alias
Clgi; EPA; TIMP-1; TPA-S1; Timp
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
X
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Timp1em1flox/Cya mice (Catalog S-CKO-06301) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000115342
NCBI RefSeq
NM_011593
Target Region
Exon 3~5
Size of Effective Region
~1.5 kb
Detailed Document
Overview of Gene Research
Timp1, also known as tissue inhibitor of metalloproteinases-1, is named for its well-established function of inhibiting the proteolytic activity of matrix metalloproteases. It can also modulate cell behavior through the induction of signaling pathways involved in cell growth, proliferation, and survival. TIMP1 is associated with many biological processes and diseases, and genetic models are valuable for studying its functions [5].
In pancreatic cancer, TIMP1 triggers neutrophil extracellular trap (NET) formation. In genetically engineered PDAC-bearing mice, abrogation of TIMP1 prolonged survival, indicating its role in promoting cancer progression through NET formation [1]. In pancreatic cancer cell-Schwann cell interaction, TIMP1 knockdown in PDAC cells suppressed perineural invasion (PNI), suggesting that TIMP1 promotes PNI through a paracrine feedback loop with CCL7 [2]. In thyroid cancer, inhibiting TIMP1 expression reduced the malignant biological traits of PTC cells and impeded M2 macrophage polarization [3]. In subarachnoid haemorrhage, TIMP1 mitigated early brain injury by protecting the blood-brain barrier integrity through regulating astrocytic β1-integrin [4]. In type 2 diabetic osteoporosis, suppression of TIMP1 expression alleviated osteoporosis progression as TIMP1 promotes ferroptosis in osteoblasts [6]. In colorectal cancer, TIMP1 can be used as a biomarker, and its expression is associated with the immunological microenvironment, drug sensitivity, and ferroptosis inhibition [7]. In thyroid cancer, HHT inhibits cancer progression by down-regulating TIMP1 and inactivating the FAK/PI3K/AKT signaling pathway [8]. In gastric cancer, TIMP1 expression is related to tumor differentiation and poor prognosis [9].
In conclusion, Timp1 plays diverse and crucial roles in multiple biological processes and diseases. The use of gene knockout or conditional knockout mouse models has significantly contributed to understanding its functions in areas such as cancer progression, neural invasion in pancreatic cancer, macrophage polarization in thyroid cancer, blood-brain barrier protection after subarachnoid haemorrhage, osteoporosis in type 2 diabetes, and biomarker discovery in colorectal and gastric cancers. These findings provide valuable insights into the underlying mechanisms of diseases and potential therapeutic targets.
References:
1. Schoeps, Benjamin, Eckfeld, Celina, Prokopchuk, Olga, Hermann, Chris D, Krüger, Achim. 2021. TIMP1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic Cancer. In Cancer research, 81, 3568-3579. doi:10.1158/0008-5472.CAN-20-4125. https://pubmed.ncbi.nlm.nih.gov/33941611/
2. Tian, Zhenfeng, Ou, Guangsheng, Su, Mingxin, Huang, Kaihong, Chen, Yinting. 2022. TIMP1 derived from pancreatic cancer cells stimulates Schwann cells and promotes the occurrence of perineural invasion. In Cancer letters, 546, 215863. doi:10.1016/j.canlet.2022.215863. https://pubmed.ncbi.nlm.nih.gov/35961511/
3. Lin, Xu, Zhao, Ruhua, Bin, Yu, Xue, Gang, Wu, Jingfang. 2024. TIMP1 promotes thyroid cancer cell progression through macrophage phenotypic polarization via the PI3K/AKT signaling pathway. In Genomics, 116, 110914. doi:10.1016/j.ygeno.2024.110914. https://pubmed.ncbi.nlm.nih.gov/39128817/
4. Tang, Tianchi, Chen, Huaijun, Hu, Libin, Chen, Gao, Liu, Fuyi. 2024. TIMP1 protects against blood-brain barrier disruption after subarachnoid haemorrhage by inhibiting ubiquitination of astrocytic β1-integrin. In Stroke and vascular neurology, 9, 671-684. doi:10.1136/svn-2023-002956. https://pubmed.ncbi.nlm.nih.gov/38485231/
5. Justo, Beatriz Laís, Jasiulionis, Miriam Galvonas. 2021. Characteristics of TIMP1, CD63, and β1-Integrin and the Functional Impact of Their Interaction in Cancer. In International journal of molecular sciences, 22, . doi:10.3390/ijms22179319. https://pubmed.ncbi.nlm.nih.gov/34502227/
6. Peng, Bo, Feng, Zhiwei, Yang, Ao, Geng, Bin, Xia, Yayi. 2024. TIMP1 regulates ferroptosis in osteoblasts by inhibiting TFRC ubiquitination: an in vitro and in vivo study. In Molecular medicine (Cambridge, Mass.), 30, 226. doi:10.1186/s10020-024-01000-9. https://pubmed.ncbi.nlm.nih.gov/39578773/
7. Qiu, Xiaode, Quan, Guangqian, Ou, Wenquan, Wang, Jian, Wu, Xiaohua. 2023. Unraveling TIMP1: a multifaceted biomarker in colorectal cancer. In Frontiers in genetics, 14, 1265137. doi:10.3389/fgene.2023.1265137. https://pubmed.ncbi.nlm.nih.gov/37842645/
8. Xi, Chuang, Zhang, Guoqiang, Sun, Nan, Luo, Quanyong, Qiu, Zhongling. 2024. Repurposing homoharringtonine for thyroid cancer treatment through TIMP1/FAK/PI3K/AKT signaling pathway. In iScience, 27, 109829. doi:10.1016/j.isci.2024.109829. https://pubmed.ncbi.nlm.nih.gov/38770133/
9. Zheng, Mingcan, Wang, Puxu, Wang, Yuhang, Chen, Hailong, Zu, Guo. 2024. Clinicopathological and prognostic significance of TIMP1 expression in gastric cancer: a systematic review and meta-analysis. In Expert review of anticancer therapy, 24, 1169-1176. doi:10.1080/14737140.2024.2408278. https://pubmed.ncbi.nlm.nih.gov/39305243/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen